ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221,196 | +2.8% | 10,614 | +18.1% | 0.00% | – |
| Q2 2023 | $215,167 | -87.2% | 8,984 | -71.4% | 0.00% | -100.0% |
| Q4 2020 | $1,677,000 | +102.5% | 31,372 | +83.8% | 0.00% | +100.0% |
| Q2 2020 | $828,000 | +1.1% | 17,073 | -11.9% | 0.00% | 0.0% |
| Q1 2020 | $819,000 | -12.0% | 19,380 | -11.0% | 0.00% | 0.0% |
| Q4 2019 | $931,000 | +83.6% | 21,770 | +54.4% | 0.00% | 0.0% |
| Q3 2019 | $507,000 | +28.7% | 14,098 | -4.3% | 0.00% | 0.0% |
| Q2 2019 | $394,000 | -16.2% | 14,731 | -9.6% | 0.00% | 0.0% |
| Q4 2016 | $470,000 | -1.1% | 16,289 | -35.9% | 0.00% | 0.0% |
| Q3 2016 | $475,000 | +47.5% | 25,393 | +29.3% | 0.00% | 0.0% |
| Q2 2016 | $322,000 | +40.6% | 19,644 | +139.4% | 0.00% | 0.0% |
| Q1 2016 | $229,000 | -89.2% | 8,204 | -86.2% | 0.00% | -87.5% |
| Q4 2015 | $2,123,000 | +13.0% | 59,551 | +4.8% | 0.01% | 0.0% |
| Q3 2015 | $1,879,000 | -10.6% | 56,807 | +13.2% | 0.01% | 0.0% |
| Q2 2015 | $2,101,000 | +34.7% | 50,171 | +4.8% | 0.01% | +14.3% |
| Q1 2015 | $1,560,000 | -5.7% | 47,876 | -8.1% | 0.01% | -12.5% |
| Q4 2014 | $1,654,000 | – | 52,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |